Trump’s Denmark Tariff Threat Sparks Concerns For Danish Drug Giant Novo Nordisk

By Maaisha Osman / January 8, 2025 at 4:28 PM
President-elect Donald Trump’s threat to "tariff Denmark at a very high level” unless the nation cedes Greenland to the United States could create new challenges for Novo Nordisk, the Danish drugmaker behind the blockbuster weight-loss and diabetes drugs Ozempic and Wegovy. A tariff on Danish products would likely drive Novo Nordisk to raise drug prices in the United States, a key market for the company, according to an expert. Novo Nordisk told Inside Health Policy that it is closely...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.